News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current DMAC market cap is 92.61M. The company's latest EPS is USD -0.5106 and P/E is -4.68.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 527k | 0 | 0 | 0 |
| Operating Income | -5.52M | -4.21M | -5.16M | -5.85M | -5.74M |
| Net Income | -5.27M | -4.48M | -4.47M | -5.16M | -5.15M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -11.59M | -12.7M | -13.65M | -14M | -21.27M |
| Net Income | -10.65M | -12.29M | -13.59M | -13.68M | -19.38M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 30.22M | 62.05M | 58.14M | 54.16M | 49.26M |
| Total Liabilities | 3.2M | 2.31M | 2.51M | 3.1M | 2.91M |
| Total Equity | 27.02M | 59.74M | 55.63M | 51.06M | 46.35M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 9.05M | 28.1M | 45.55M | 34.4M | 54.16M |
| Total Liabilities | 1.44M | 2.08M | 1.53M | 2.57M | 3.1M |
| Total Equity | 7.62M | 26.01M | 44.02M | 31.83M | 51.06M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -5.09M | -10.12M | -14.92M | -18.73M | -6.65M |
| Investing | 2.51M | -25.62M | -24.42M | -18.3M | 4.21M |
| Financing | -1,000 | 36.85M | 36.84M | 36.84M | -1,000 |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -9.1M | -9.19M | -12.25M | -11.51M | -18.73M |
| Investing | -3.91M | -16.13M | -20.54M | 11.54M | -18.3M |
| Financing | 70k | 28.85M | 30.09M | -6k | 36.84M |
| Market Cap | 92.61M |
| Price to Earnings Ratio | -4.68 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 19.97 |
| Price to Book Ratio | 1.78 |
| Dividend Yield | - |
| Shares Outstanding | 37.95M |
| Average Volume (1 week) | 30.81k |
| Average Volume (1 Month) | 21.03k |
| 52 Week Change | -34.05% |
| 52 Week High | 4.75 |
| 52 Week Low | 1.9382 |
| Spread (Intraday) | 0.14 (5.65%) |
| Company Name | DiaMedica Therapeutics Inc |
| Address |
301 carlson parkway, suite 210 minneapolis, minnesota 55305 |
| Website | https://www.diamedica.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
